XML 106 R85.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Goodwill and Other Intangibles Other Intangibles (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Gross Asset Value, Beginning Balance |  | $ 129,873 |  | $ 200,418 |  |
Divestitures | [1] |  |  | (68,540) |  |
Reclass to assets held for sale | [2] | (72,122) |  |  |  |
Foreign currency translation adjustments and other |  | (135,185) |  | (7,233) |  |
Gross Asset Value, Ending Balance |  | 1,881,718 |  | 129,873 |  | $ 200,418
Accumulated Amortization, Beginning Balance |  | (85,748) |  | (112,215) |  |
Amortization |  | (77,282) |  | (5,737) |  | (8,100)
Removal of Accumulated Amortization of Intangible Assets From Impairment | [1] |  |  | 27,584 |  |
Reclass to assets held for sale | [2] | 5,798 |  |  |  |
Foreign currency translation adjustments and other |  | 8,561 |  | 4,620 |  |
Accumulated Amortization, Ending Balance |  | (148,671) |  | (85,748) |  | (112,215)
Net Book Value |  | 1,733,047 |  | 44,125 |  |
Customer Lists and Relationships |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Gross Asset Value, Beginning Balance |  | 48,479 |  | 86,426 |  |
Divestitures |  |  |  | (34,892) |  |
Reclass to assets held for sale | [2] | (16,608) |  |  |  |
Foreign currency translation adjustments and other |  | (88,092) |  | (3,055) |  |
Gross Asset Value, Ending Balance |  | 1,284,057 |  | 48,479 |  | 86,426
Accumulated Amortization, Beginning Balance |  | (22,931) |  | (35,988) |  |
Amortization |  | (51,926) |  | (2,839) |  |
Removal of Accumulated Amortization of Intangible Assets From Impairment |  |  |  | 14,487 |  |
Reclass to assets held for sale | [2] | 596 |  |  |  |
Foreign currency translation adjustments and other |  | 2,303 |  | 1,409 |  |
Accumulated Amortization, Ending Balance |  | (71,958) |  | (22,931) |  | (35,988)
Net Book Value |  | 1,212,099 |  | 25,548 |  |
Trademarks and Trade Names |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Gross Asset Value, Beginning Balance |  | 17,555 | [3] | 26,907 |  |
Divestitures |  |  |  | (8,171) |  |
Reclass to assets held for sale | [2] | 0 |  |  |  |
Foreign currency translation adjustments and other |  | (25,468) |  | (1,181) |  |
Gross Asset Value, Ending Balance |  | 355,207 | [3] | 17,555 | [3] | 26,907
Accumulated Amortization, Beginning Balance |  | (7,912) |  | (8,970) |  |
Amortization |  | (12,228) |  | (824) |  |
Removal of Accumulated Amortization of Intangible Assets From Impairment |  |  |  | 1,539 |  |
Reclass to assets held for sale | [2] | 0 |  |  |  |
Foreign currency translation adjustments and other |  | 381 |  | 343 |  |
Accumulated Amortization, Ending Balance |  | (19,759) |  | (7,912) |  | (8,970)
Net Book Value |  | 335,448 |  | 9,643 |  |
Patents and Technology |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Gross Asset Value, Beginning Balance |  | 40,398 |  | 48,743 |  |
Divestitures |  |  |  | (11,316) |  |
Reclass to assets held for sale | [2] | (54,060) |  |  |  |
Foreign currency translation adjustments and other |  | (15,508) |  | (2,257) |  |
Gross Asset Value, Ending Balance |  | 200,101 |  | 40,398 |  | 48,743
Accumulated Amortization, Beginning Balance |  | (32,831) |  | (40,354) |  |
Amortization |  | (12,501) |  | (388) |  |
Removal of Accumulated Amortization of Intangible Assets From Impairment |  |  |  | 5,738 |  |
Reclass to assets held for sale | [2] | 3,880 |  |  |  |
Foreign currency translation adjustments and other |  | 1,675 |  | 2,173 |  |
Accumulated Amortization, Ending Balance |  | (39,777) |  | (32,831) |  | (40,354)
Net Book Value |  | 160,324 |  | 7,567 |  |
Other |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Gross Asset Value, Beginning Balance |  | 23,441 |  | 38,342 |  |
Divestitures |  |  |  | (14,161) |  |
Reclass to assets held for sale | [2] | (1,454) |  |  |  |
Foreign currency translation adjustments and other |  | (6,117) |  | (740) |  |
Gross Asset Value, Ending Balance |  | 42,353 | [4] | 23,441 |  | 38,342
Accumulated Amortization, Beginning Balance |  | (22,074) |  | (26,903) |  |
Amortization |  | (627) |  | (1,686) |  |
Removal of Accumulated Amortization of Intangible Assets From Impairment |  |  |  | 5,820 |  |
Reclass to assets held for sale | [2] | 1,322 |  |  |  |
Foreign currency translation adjustments and other |  | 4,202 |  | 695 |  |
Accumulated Amortization, Ending Balance |  | (17,177) |  | (22,074) |  | (26,903)
Net Book Value |  | 25,176 |  | 1,367 |  |
Antioxidant, Ibuprofen and Propofol Assets |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Divestitures |  |  |  | (68,500) |  |
Amortization |  |  |  | (900) |  | $ (3,500)
Removal of Accumulated Amortization of Intangible Assets From Impairment |  |  |  | 27,600 |  |
Cambridge Chemical Company |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [5] |  |  | 5,228 |  |
Cambridge Chemical Company | Customer Lists and Relationships |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  |  |  | 0 |  |
Cambridge Chemical Company | Trademarks and Trade Names |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  |  |  | 0 |  |
Cambridge Chemical Company | Patents and Technology |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [5] |  |  | 5,228 |  |
Cambridge Chemical Company | Other |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  |  |  | $ 0 |  |
Rockwood Holdings, Inc. |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  | 1,881,594 |  |  |  |
Rockwood Holdings, Inc. | Customer Lists and Relationships |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  | 1,264,226 |  |  |  |
Rockwood Holdings, Inc. | Trademarks and Trade Names |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  | 363,120 |  |  |  |
Rockwood Holdings, Inc. | Patents and Technology |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  | 227,838 |  |  |  |
Rockwood Holdings, Inc. | Other |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions |  | 26,410 |  |  |  |
Other significant projects |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [6] | 77,558 |  |  |  |
Other significant projects | Customer Lists and Relationships |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [6] | 76,052 |  |  |  |
Other significant projects | Trademarks and Trade Names |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [6] | 0 |  |  |  |
Other significant projects | Patents and Technology |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [6] | 1,433 |  |  |  |
Other significant projects | Other |  |  |  |  |  |
Finite-lived Intangible Assets [Roll Forward] |  |  |  |  |  |
Acquisitions | [6] | $ 73 |  |  |  |
[1] | In 2014 we reduced intangible assets by $68.5 million and related accumulated amortization by $27.6 million in connection with the sale of our antioxidant, ibuprofen and propofol businesses and assets which closed on September 1, 2014. See Note 3 “Divestitures” for additional information about this transaction.
[2] | See Note 3, “Divestitures.”
[3] | Included in Trade Names and Trademarks are indefinite-lived intangible assets with a gross carrying amount of $9.2 million and $113.1 million at December 31, 2014 and 2015, respectively.
[4] | Included in Other is an indefinite-lived intangible asset with a gross carrying amount of $21.9 million at December 31, 2015.
[5] | Increase in Patents and Technology relates to a purchase accounting adjustment in connection with our acquisition of Cambridge Chemical Company, Ltd.
[6] | Primarily relates to the acquisition of the remaining interest in Shanghai Chemetall. See Note 2, “Acquisitions.”

X
- Definition Finite lived intangible assets accumulated amortization foreign exchange impact. + References No definition available. + Details
Name: | alb_FiniteLivedIntangibleAssetsAccumulatedAmortizationForeignExchangeImpact
Namespace Prefix: | alb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Finite Lived Intangible Assets Accumulated Amortization Reclass to Assets Held for Sale + References No definition available. + Details
Name: | alb_FiniteLivedIntangibleAssetsAccumulatedAmortizationReclasstoAssetsHeldforSale
Namespace Prefix: | alb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Finite Lived Intangible Assets, Reclass to Assets Held for Sale + References No definition available. + Details
Name: | alb_FiniteLivedIntangibleAssetsReclasstoAssetsHeldforSale
Namespace Prefix: | alb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Removal of Accumulated Amortization of Intangible Assets From Impairment + References No definition available. + Details
Name: | alb_RemovalofAccumulatedAmortizationofIntangibleAssetsFromImpairment
Namespace Prefix: | alb_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsRollForward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for foreign currency translation adjustments. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsTranslationAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alb_CustomerListsAndRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alb_PatentsAndTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alb_AntioxidantIbuprofenandPropofolAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=alb_CambridgeChemicalCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=alb_RockwoodHoldingsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=alb_OthersignificantprojectsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |